Akanda (FRA:Y232) Moat Score: 1/10 (As of Jun. 27, 2026)


FRA:Y232 Akanda Corp FRA:Y232
12 GF Score
Price €11.60
! 9 Warning Signs
View Full Analysis

What is Akanda Moat Score?

Akanda FRA:Y232 -14.71% 12 Moat Score is 1 as of Jun. 27, 2026. GuruFocus rates FRA:Y232 with a GF Score™ of 12/100. The stock has 9 warning signs investors should review. Among 1,033 Drug Manufacturers companies, Akanda ranks better than 76.28% on this metric.

Akanda has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Akanda has No Moat: Akanda Corp operates in a nascent and highly competitive cannabis industry with no significant market leadership, customer loyalty, or intellectual property. The company lacks durable cost advantages or regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Akanda might have No Moat - Very weak/transient advantages.

Akanda  (FRA:Y232) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Akanda Moat Score Related Terms

FRA:Y232 vs BFRI, BIOE, CABR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Akanda's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akanda Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akanda's Moat Score distribution charts can be found below:

* The bar in red indicates where Akanda's Moat Score falls into.


FRA:Y232
12GF Score
Akanda Corp FRA:Y232
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Akanda (FRA:Y232) has a Moat Score of 1 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Akanda ranks #245 out of 1033 companies in the Drug Manufacturers industry, placing it in the top 23.7%.
Is Akanda's Moat Score too high?
Akanda's current Moat Score is 1. Based on the distribution chart, Akanda ranks #245 out of 1033 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Akanda has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Akanda's Moat Score compare to BFRI and BIOE?
According to the Drug Manufacturers industry distribution chart, Akanda ranks #245 out of 1033 companies for Moat Score. This places Akanda in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Akanda's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akanda stock overvalued right now?
Akanda (FRA:Y232) has a current Moat Score of 1. The current Moat Score is 1. Akanda's overall GF Score™ is 12/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Akanda (FRA:Y232), the current Moat Score is 1 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Akanda Business Description

Other Exchanges AKAN:USA
Address c/o Gowling WLG (Canada) LLP, 100 King Street W, Suite 1600, Toronto, ON, CAN, M5X 1G5
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company is a medical cannabis & hemp and wellness platform company seeking to help people lives through improved access to high-quality and affordable products. The Company is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary. The company has four reportable segments: Infrastructure, Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Infrastructure segment, which relates to the leasing and/or rental of fiber optic networks and telecommunication towers at First Towers in Mexico.
12GF Score

Get the complete analysis for FRA:Y232

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.60
Price